Strategic partnerships Avalon Health Economics collaborates with diverse stakeholders including life sciences companies, health care providers, trade associations, universities, foundations, and law firms, presenting opportunities to expand services through cross-industry consulting engagements and joint projects.

Real-world evidence focus Specializing in data-driven health economics and outcomes research and real-world evidence, Avalon can offer subscription-like analytics, custom HEOR studies, and policy analysis services to pharma, biotech, and device clients seeking robust outcomes data.

Global collaboration Past collaboration with Oberender indicates openness to international partnerships, enabling co-led studies, global health economics projects, and expansion into European healthcare markets.

Growth potential With a revenue range of one to ten million and a lean team size, Avalon presents a scalable model for white-label HEOR offerings, managed services, and tiered consulting packages to both niche and large enterprise clients.

Market positioning Operating in the healthcare analytics and policy space with competitive differentiators in accuracy, defensible research, and attentive project management, Avalon can target mid-market life sciences firms and healthcare providers seeking value-led, compliant HEOR solutions.